Review



t5 caption a7 antibiotic s mic  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC t5 caption a7 antibiotic s mic
    T5 Caption A7 Antibiotic S Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 17828 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t5+caption+a7+antibiotic+s+mic/MIC/pmc00089260-74-60-79
    Average 99 stars, based on 17828 article reviews
    t5 caption a7 antibiotic s mic - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: Diversification of Escherichia coli Expressing an SHV-Type Extended-Spectrum ?-Lactamase (ESBL) during a Hospital Outbreak: Emergence of an ESBL-Hyperproducing Strain Resistant to Expanded-Spectrum Cephalosporins
    Article Snippet: .. The MICs characterizing E. coli isolate 173/97 were very similar to those for the susceptible isolates. table ft1 table-wrap mode="anchored" t5 caption a7 Antibiotic(s) MIC (μg/ml) for bacterial strain(s): Resistant group ( n = 5) Susceptible group ( n = 7) E. coli 173/97 b ( n = 1) E. coli ATCC 25922 Ampicillin >512 256 256 4 Piperacillin 256 16 32 2 Piperacillin + tazobactam c 2 1 1 2 Ceftazidime 128 4 4 0.25 Ceftazidime + clavulanate d 0.125 0.06 0.06 0.125 Cefotaxime 32 1 1 0.06 Cefotaxime + clavulanate ≤0.03 ≤0.03 ≤0.03 ≤0.03 Cefepime 16 1 0.5 0.06 Cefepime + clavulanate 0.06 0.06 0.06 0.06 Ceftibuten 8 0.5 0.5 0.25 Ceftibuten + clavulanate 0.125 0.125 0.125 0.25 Aztreonam 256 8 8 0.125 Aztreonam + clavulanate ≤0.03 ≤0.03 ≤0.03 0.06 Cefoxitin 8 4 2 2 Imipenem 0.06 0.06 0.125 0.06 Gentamicin 8 8 8 1 Amikacin 16 16 16 1 Open in a separate window a This method is described in reference 13 . b E. coli 173/97 was isolated in December 1996 (10 months before the outbreak). c The concentration of tazobactam was 4 μg/ml. d The concentration of clavulanate was constant at 2 μg/ml in all combinations. ..

    Concentration Assay:

    Article Title: Diversification of Escherichia coli Expressing an SHV-Type Extended-Spectrum ?-Lactamase (ESBL) during a Hospital Outbreak: Emergence of an ESBL-Hyperproducing Strain Resistant to Expanded-Spectrum Cephalosporins
    Article Snippet: .. The MICs characterizing E. coli isolate 173/97 were very similar to those for the susceptible isolates. table ft1 table-wrap mode="anchored" t5 caption a7 Antibiotic(s) MIC (μg/ml) for bacterial strain(s): Resistant group ( n = 5) Susceptible group ( n = 7) E. coli 173/97 b ( n = 1) E. coli ATCC 25922 Ampicillin >512 256 256 4 Piperacillin 256 16 32 2 Piperacillin + tazobactam c 2 1 1 2 Ceftazidime 128 4 4 0.25 Ceftazidime + clavulanate d 0.125 0.06 0.06 0.125 Cefotaxime 32 1 1 0.06 Cefotaxime + clavulanate ≤0.03 ≤0.03 ≤0.03 ≤0.03 Cefepime 16 1 0.5 0.06 Cefepime + clavulanate 0.06 0.06 0.06 0.06 Ceftibuten 8 0.5 0.5 0.25 Ceftibuten + clavulanate 0.125 0.125 0.125 0.25 Aztreonam 256 8 8 0.125 Aztreonam + clavulanate ≤0.03 ≤0.03 ≤0.03 0.06 Cefoxitin 8 4 2 2 Imipenem 0.06 0.06 0.125 0.06 Gentamicin 8 8 8 1 Amikacin 16 16 16 1 Open in a separate window a This method is described in reference 13 . b E. coli 173/97 was isolated in December 1996 (10 months before the outbreak). c The concentration of tazobactam was 4 μg/ml. d The concentration of clavulanate was constant at 2 μg/ml in all combinations. ..

    Article Title: An SHV-Derived Extended-Spectrum ?-Lactamase in Pseudomonas aeruginosa
    Article Snippet: .. Crude extracts from P. aeruginosa RP-1 and from E. coli JM109(pPL20) were analyzed by isoelectric focusing ( 23 ) and revealed a β-lactamase with a pI of 7.6 in both cases and an additional β-lactamase with a pI of 8.2 (likely corresponding to an AmpC cephalosporinase) found only in P. aeruginosa RP-1 extracts (data not shown). table ft1 table-wrap mode="anchored" t5 caption a7 Antibiotic(s) MIC (μg/ml) against: P. aeruginosa RP-1 E. coli JM109 (pPL20) E. coli JM109 P. aeruginosa ATCC 27853 P. aeruginosa Mut Amoxicillin >512 512 2 >512 >512 Amoxicillin + CLA a >512 4 2 >512 >512 Ticarcillin >512 >512 2 2 32 Ticarcillin + CLA 64 4 1 2 32 Piperacillin 256 256 1 1 16 Piperacillin + CLA 32 2 1 1 16 Cephalothin >512 >512 4 >512 >512 Cephalothin + CLA >512 4 2 >512 >512 Cefoxitin >512 8 8 >512 >512 Ceftazidime 32 8 0.25 0.25 8 Ceftazidime + CLA 8 0.25 0.25 0.25 8 Cefotaxime >512 32 0.06 2 >512 Cefotaxime + CLA 256 0.12 0.06 2 >512 Imipenem 2 0.12 0.06 0.5 0.5 Aztreonam 32 8 0.12 0.5 2 Aztreonam + CLA 16 0.12 0.12 0.5 2 Open in a separate window a CLA, clavulanic acid at a fixed concentration of 2 μg/ml (MIC for E. coli JM109, 16 μg/ml). .. MICs of β-lactams for P. aeruginosa RP-1, E. coli JM109 harboring recombinant plasmid pPL20, reference strain E. coli JM109, reference strain P. aeruginosa ATCC 27853, and its stably derepressed cephalosporinase-producing mutant, Mut The 2.9-kb cloned fragment from pPL20 was sequenced on both strands with an Applied Biosystems ABI 377 sequencer.



    Similar Products

    t5 caption a7 antibiotic s mic  (ATCC)
    99
    ATCC t5 caption a7 antibiotic s mic
    T5 Caption A7 Antibiotic S Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/t5+caption+a7+antibiotic+s+mic/MIC/pmc00089260-74-60-79
    Average 99 stars, based on 1 article reviews
    t5 caption a7 antibiotic s mic - by Bioz Stars, 2026-09
    99/100 stars
    		  Buy from Supplier

    Image Search Results